Starmer remains an enigma in the eyes of many voters, who are predicted to propel him to Downing Street after Thursday's general election
world1 day ago
An Indian government-approved expert panel has advised the country's drug regulator to approve the import and sale of US drugmaker Eli Lilly's Mounjaro, a blockbuster diabetes drug and a wildly popular obesity treatment, a document on a government website showed on Monday.
Lilly's Mounjaro, chemically known as tirzepatide, and Zepbound and Danish rival Novo Nordisk's Wegovy and Ozempic belong to a class of therapies known as GLP-1 receptor agonists, developed to control blood sugar in patients with type 2 diabetes.
They also slow digestion, helping patients feel full longer, making them a wildly popular choice for weight loss.
"After detailed deliberation, the committee recommended for grant of permission for import and marketing" of certain doses of tirzepatide "for chronic weight management subject to the condition that firm should conduct Phase 4 clinical trial (post-marketing surveillance)," the Subject Expert Committee said in a notification dated June 19.
The committee advises India's drug regulator on approvals of drugs and trials.
"A recommendation from the subject expert committee is like the penultimate step of the approval," said Sheetal Sapale, vice-president of research firm Pharmarack.
Lilly did not immediately respond to a Reuters request for comment. CEO David Ricks had told Reuters a few months back that the company expected to launch Mounjaro in India as early as next year.
India has the world's second-highest number of people with type 2 diabetes and high obesity rates. Around 11 per cent of Indian adults will be obese by 2035, per the World Obesity Federation Atlas. The global weight-loss drugs market is estimated to reach at least $100 billion by the decade's end.
Lilly should also submit the required manufacturing and controls data, the expert panel added.
The notification was first reported by a local medical journal, The Indian Practitioner.
Starmer remains an enigma in the eyes of many voters, who are predicted to propel him to Downing Street after Thursday's general election
world1 day ago
Ramaphosa's new coalition is the first of its kind in the country after 30 years of rule by the African National Congress
world2 days ago
Turk blames the rise of populist, extremist politics on the Covid-19 pandemic and rising living costs that have 'disenfranchised, disillusioned, a large segment of the population'
world2 days ago
The scheme, uncovered by journalists and families searching for lost relatives, saw babies stolen from their mothers and then sold to adoptive parents in Georgia and abroad
world2 days ago
The authority affirmed its concern for all of its citizens and guaranteed on following up on their safety
world2 days ago
More than 150,000 people in the Palestinian territory have contracted skin diseases due to the squalid living conditions, according to the World Health Organisation
world2 days ago
It will result, at the very least, in delays to any further trials of Trump, and may lead to cases being thrown out altogether, say legal experts
world2 days ago
Wildfires have become more common and devastating in Greece in recent years because of climate change, according to scientists
world2 days ago